NCT07290543

Brief Summary

This clinical trial tests how well a web based toolkit works to improve cancer related emotional distress and anxiety in rural older cancer survivors. Rural older adults with cancer-related distress are particularly vulnerable to poorer mental health and cancer-related outcomes including increased difficulties identifying symptoms of anxiety, a reduced likelihood of knowing when to access mental health services, and a higher likelihood of having poorly managed CRD, even after receiving a psychosocial referral. The web based tool kit called CONNECT addresses digital literacy and supports for cancer-related distress management through interactive activities for setting up telehealth visits, accessing educational materials about cancer-related distress, and providing individualized mental health resource recommendations. Using CONNECT may improve cancer related emotional distress and anxiety in rural older cancer survivors.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
578

participants targeted

Target at P75+ for not_applicable

Timeline
77mo left

Started Aug 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Aug 2025Aug 2032

Study Start

First participant enrolled

August 26, 2025

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

September 24, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 18, 2025

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 26, 2031

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 26, 2032

Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

6 years

First QC Date

September 24, 2025

Last Update Submit

December 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cancer Related Distress (validated 23-item scale)

    Cancer-related distress will be measured using the Cancer and Treatment Distress Scale (23 items; item scores 0-3; higher scores indicate greater distress). The CTXD assesses distress over the past week and includes six subscales: (1) uncertainty, (2) family strain, (3) health burden, (4) finances, (5) identity/appearance, and (6) medical demands. The primary outcome is the mean cumulative score across all items and subscales. A mean score above 0.85 indicates elevated distress in long-term survivors. The CTXD has demonstrated high validity and reliability across time, from pre-treatment to 18 years post-treatment, with Cronbach's alphas ranging from 0.77 to 0.90. The subscales align with the psychosocial domain identified in the NCCN Guidelines for Distress Management.

    Up to 1 year

Secondary Outcomes (5)

  • Self-reported Healthcare Resource Usage

    Up to 12 months

  • Self-reported Shared Device Use

    Up to 12 months

  • Telehealth Utilization (self-reported use of portal, completed visits, and visit modality)

    Up to 12 months

  • Cancer Survivors' Unmet Needs (validated 35-item scale)

    Up to 12 months

  • Caregiver Strain Index (validated 13-item scale)

    Up to 12 months

Study Arms (3)

Arm I (Advisory board)

EXPERIMENTAL

Advisory board members complete small group workshops, interviews and surveys on study.

Other: InterviewOther: Survey Administration

Arm II (CONNECT platform)

EXPERIMENTAL

Patients and their caregivers receive access to the CONNECT platform, which includes educational materials on distress management, guides to telehealth and personalized recommendations for resources. Patients and their caregivers complete a guided tutorial of the platform with a research assistant at the start of the intervention period, receive biweekly phone calls with the research assistant, for 20 minutes starting on 14 days to 2 months to review the four cancer-related management functions and receive a text message reminders to encourage use, every 2 weeks for 4 months.

Other: Educational InterventionOther: Internet-Based InterventionOther: InterviewBehavioral: Patient NavigationOther: Survey AdministrationBehavioral: Telephone-Based InterventionOther: Text Message-Based Navigation Intervention

Arm III (Educational brochure)

ACTIVE COMPARATOR

Patients are mailed an educational brochure about distress management on study.

Other: Educational InterventionOther: InterviewOther: Survey Administration

Interventions

Receive educational materials on distress management and guides to telehealth

Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Arm II (CONNECT platform)

Receive access to CONNECT platform

Arm II (CONNECT platform)

Complete interview

Arm I (Advisory board)Arm II (CONNECT platform)Arm III (Educational brochure)

Receive personalized recommendations for resources

Also known as: Patient Navigator Program
Arm II (CONNECT platform)

Ancillary study

Arm I (Advisory board)Arm II (CONNECT platform)Arm III (Educational brochure)

Complete calls with research assistant

Arm II (CONNECT platform)

Receive text message reminders

Also known as: Automated Text Message-Based Navigation, Text Message-Based Navigation
Arm II (CONNECT platform)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • AIM 1: Invited by a member of the study team
  • AIM 1: In the following or related field:
  • Healthcare professionals (physicians, nurses, pharmacists, etc.)
  • Patient advocates and representatives
  • Researchers in healthcare or technology fields
  • Healthcare administrators and managers
  • AIM 1: Must be over 18 years old
  • AIM 1: English-speaking
  • AIM 1: Willing and able to provide informed consent
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): A rural resident based on the Health Resources \& Services Administration (HRSA) rural analyzer
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Self-report of diagnosis with any cancer
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Self-report posttreatment (i.e., completion of curative intent therapy including surgery, chemotherapy, molecularly targeted, and endocrine therapy)
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Have access to a computer, a smartphone, or a tablet computer
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Aged \> 65 years old
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Assessed as having Cancer and Treatment Distress scale (CTXD) scores \> 0.85 at screening
  • +11 more criteria

You may not qualify if:

  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Experience a cancer recurrence or a new cancer diagnosis during their participation in the trial because of the body of literature that reports increased distress associated with cancer recurrence
  • AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Are inpatients
  • AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Cognitive impairment precludes the ability to provide written consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern University

Chicago, Illinois, 60611, United States

RECRUITING

MeSH Terms

Interventions

Early Intervention, EducationalEducational StatusMethodsInterviews as TopicPatient Navigation

Intervention Hierarchy (Ancestors)

Child Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health ServicesSocioeconomic FactorsPopulation CharacteristicsInvestigative TechniquesData CollectionEpidemiologic MethodsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPatient-Centered CarePrimary Health CareComprehensive Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Marquita W Lewis, PhD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Study staff abstracting the data will be blinded to the participant's condition.
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 24, 2025

First Posted

December 18, 2025

Study Start

August 26, 2025

Primary Completion (Estimated)

August 26, 2031

Study Completion (Estimated)

August 26, 2032

Last Updated

December 18, 2025

Record last verified: 2025-12

Locations